Deprescribing within English care homes: guidance and recommendations from the STOPPING project

Background Care home residents often experience polypharmacy. Deprescribing, or the reduction or stopping of prescription medicines that may no longer be providing benefit, is generally safe but it is unknown how to make it work well in care homes.Aim Develop recommendations and guidance for impleme...

Full description

Saved in:
Bibliographic Details
Main Authors: Krystal Warmoth, Alex Aylward, Jo Day
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Health Literacy and Communication Open
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/28355245.2024.2445716
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850240195545268224
author Krystal Warmoth
Alex Aylward
Jo Day
author_facet Krystal Warmoth
Alex Aylward
Jo Day
author_sort Krystal Warmoth
collection DOAJ
description Background Care home residents often experience polypharmacy. Deprescribing, or the reduction or stopping of prescription medicines that may no longer be providing benefit, is generally safe but it is unknown how to make it work well in care homes.Aim Develop recommendations and guidance for implementing a deprescribing approach that is feasible and suitable within care homes.Methods The findings from two qualitative work packages of the STOPPING project were synthesised to inform guidance for deprescribing within care homes. In total, 42 interviews were conducted with 36 participants from 15 different care homes. A framework analysis approach, informed by an implementation science framework, was used to analyse and combine data from both work packages.Results Key considerations for deprescribing in care homes are as follows: engaging multiple individuals and organisations; recognising their various roles, responsibilities, expertise, and beliefs; information access and sharing; and active monitoring of the impact of deprescribing. The key factor is the quality of local working relationships.Discussion Communication and collaboration between care homes and healthcare professionals are essential to ensure deprescribing is done well. The guidance suggests several courses of action and resources for how to improve future deprescribing in care homes.
format Article
id doaj-art-1f0e2ff5bae54a589ec9974f91bb0995
institution OA Journals
issn 2835-5245
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Health Literacy and Communication Open
spelling doaj-art-1f0e2ff5bae54a589ec9974f91bb09952025-08-20T02:00:55ZengTaylor & Francis GroupHealth Literacy and Communication Open2835-52452025-12-013110.1080/28355245.2024.2445716Deprescribing within English care homes: guidance and recommendations from the STOPPING projectKrystal Warmoth0Alex Aylward1Jo Day2Centre for Research In Public Health And Community Care (CRIPACC), School of Health and Social Work, University of Hertfordshire, Hatfield, UKNIHR Applied Research Collaboration South West Peninsula (PenARC), Patient Engagement Group, University of Exeter, Exeter, UKDepartment of Health and Community Sciences, Faculty of Health and Life Sciences, University of Exeter Medical School, Exeter, UKBackground Care home residents often experience polypharmacy. Deprescribing, or the reduction or stopping of prescription medicines that may no longer be providing benefit, is generally safe but it is unknown how to make it work well in care homes.Aim Develop recommendations and guidance for implementing a deprescribing approach that is feasible and suitable within care homes.Methods The findings from two qualitative work packages of the STOPPING project were synthesised to inform guidance for deprescribing within care homes. In total, 42 interviews were conducted with 36 participants from 15 different care homes. A framework analysis approach, informed by an implementation science framework, was used to analyse and combine data from both work packages.Results Key considerations for deprescribing in care homes are as follows: engaging multiple individuals and organisations; recognising their various roles, responsibilities, expertise, and beliefs; information access and sharing; and active monitoring of the impact of deprescribing. The key factor is the quality of local working relationships.Discussion Communication and collaboration between care homes and healthcare professionals are essential to ensure deprescribing is done well. The guidance suggests several courses of action and resources for how to improve future deprescribing in care homes.https://www.tandfonline.com/doi/10.1080/28355245.2024.2445716Deprescribingmedicine optimisationlong-term careolder adultspolypharmacy
spellingShingle Krystal Warmoth
Alex Aylward
Jo Day
Deprescribing within English care homes: guidance and recommendations from the STOPPING project
Health Literacy and Communication Open
Deprescribing
medicine optimisation
long-term care
older adults
polypharmacy
title Deprescribing within English care homes: guidance and recommendations from the STOPPING project
title_full Deprescribing within English care homes: guidance and recommendations from the STOPPING project
title_fullStr Deprescribing within English care homes: guidance and recommendations from the STOPPING project
title_full_unstemmed Deprescribing within English care homes: guidance and recommendations from the STOPPING project
title_short Deprescribing within English care homes: guidance and recommendations from the STOPPING project
title_sort deprescribing within english care homes guidance and recommendations from the stopping project
topic Deprescribing
medicine optimisation
long-term care
older adults
polypharmacy
url https://www.tandfonline.com/doi/10.1080/28355245.2024.2445716
work_keys_str_mv AT krystalwarmoth deprescribingwithinenglishcarehomesguidanceandrecommendationsfromthestoppingproject
AT alexaylward deprescribingwithinenglishcarehomesguidanceandrecommendationsfromthestoppingproject
AT joday deprescribingwithinenglishcarehomesguidanceandrecommendationsfromthestoppingproject